Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.28% | $1.64B | €402.31B | 43.23% | 76 Outperform | |
| Roche Holding AG | 1.39% | $994.72M | CHF260.02B | 44.72% | 73 Outperform | |
| AstraZeneca | 1.35% | $972.95M | £207.51B | 24.94% | 80 Outperform | |
| HSBC Holdings | 1.34% | $963.83M | £207.34B | 53.88% | 80 Outperform | |
| Novartis AG | 1.25% | $899.93M | CHF206.50B | 21.96% | 80 Outperform | |
| SAP SE | 1.20% | $864.13M | €240.66B | -12.63% | 66 Neutral | |
| Nestlé SA | 1.19% | $852.61M | CHF193.19B | 19.88% | 71 Outperform | |
| Siemens | 1.04% | $748.25M | €190.85B | 26.26% | 74 Outperform | |
| Shell (UK) | 1.04% | $743.37M | £155.86B | 6.23% | 73 Outperform | |
| Toyota Motor | 0.99% | $712.12M | ¥44.30T | 12.89% | 80 Outperform |